Brief: Pacira Biosciences posts Q1 revenue USD 160.3 million
03/05/2023 14:09
May 3 (Reuters) - Pacira Biosciences Q1 cash & investments USD 182.3 million. * Q1 adjusted EBITDA USD 41.9 million * Q1 net income USD -19.5 million * Q1 adjusted net income USD 24.3 million * Q1 revenue USD 160.3 million
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees